Hypersensitivity adverse drug reactions in children: Pathophysiology and therapeutic implications

被引:1
|
作者
Rieder, MJ
机构
[1] Childrens Hosp Western Ontario, Dept Pediat, Sect Paediat Clin Pharmacol Toxicol & Expt Therap, London, ON N6C 2V5, Canada
[2] Univ Western Ontario, Dept Paediat, London, ON, Canada
[3] Univ Western Ontario, Dept Pharmacol & Toxicol, London, ON, Canada
[4] Univ Western Ontario, Dept Med, London, ON, Canada
关键词
hypersensitivity; adverse drug reactions; pathophysiology; children;
D O I
10.1016/S0011-393X(01)80095-3
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Adverse drug reactions are common problems for children and adults. Among the most serious are hypersensitivity reactions. The pathogenesis of these reactions has not been understood, but recently there have been new insights into the mechanism(s) responsible for these complex adverse drug reactions. Objectives: The goals of this paper were to review potential mechanisms for hypersensitivity adverse drug reactions and to relate these mechanisms to the care of children with hypersensitivity reactions. Methods: A search for original research in the pathogenesis of hypersensitivity adverse drug reactions was done using MEDLINE from 1985 to 2001. Other databases were not consulted. The research reviewed was confined to that described in English. Results: Hypersensitivity adverse drug reactions appear to be initiated by metabolism of the parent drug to reactive intermediates. The ongoing propagation of these reactions appears to be mediated by immunity. The mechanism(s) involved in the immunopathogenesis of drug hypersensitivity reactions mediated by reactive drug metabolites remains unclear, but may include changes in T-cell responses mediated by changes in T-cell signaling. Conclusions: Hypersensitivity adverse drug reactions are important challenges for health care workers caring for children. Health care workers need to be vigilant for the development of hypersensitivity adverse drug reactions and be aware that these reactions may continue to evolve clinically despite discontinuation of the drug in question.
引用
收藏
页码:913 / 929
页数:17
相关论文
共 50 条
  • [11] Pharmacogenomics and adverse drug reactions in children
    Rieder, Michael J.
    Carleton, Bruce
    FRONTIERS IN GENETICS, 2014, 5
  • [12] Reporting of adverse drug reactions in children
    Seyberth, H. W.
    MONATSSCHRIFT KINDERHEILKUNDE, 2008, 156 (01) : 63 - 64
  • [13] Children and ADRs (Adverse Drug Reactions)
    Napoleone, Ettore
    ITALIAN JOURNAL OF PEDIATRICS, 2010, 36
  • [14] Analysis Of Adverse Drug Reactions In Children
    Park, G. M.
    Seo, J. H.
    Kim, H. Y.
    Hwang, Y. W.
    Na, Y. S.
    Song, Y. C.
    Yu, J. H.
    Hong, S. J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB99 - AB99
  • [16] Children and ADRs (Adverse Drug Reactions)
    Ettore Napoleone
    Italian Journal of Pediatrics, 36
  • [17] Antibiotic hypersensitivity and adverse reactions: management and implications in clinical practice
    Jourdan, Anthony
    Sangha, Brijit
    Kim, Eric
    Nawaz, Sohrab
    Malik, Vikram
    Vij, Radhika
    Sekhsaria, Sudhir
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2020, 16 (01):
  • [18] Antibiotic hypersensitivity and adverse reactions: management and implications in clinical practice
    Anthony Jourdan
    Brijit Sangha
    Eric Kim
    Sohrab Nawaz
    Vikram Malik
    Radhika Vij
    Sudhir Sekhsaria
    Allergy, Asthma & Clinical Immunology, 16
  • [19] Immune-Related Adverse Drug Reactions and Immunologically Mediated Drug Hypersensitivity
    Macy, Eric
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2020, 40 (04) : 635 - 647
  • [20] Adverse drug reactions: implications for the development of fluoroquinolones
    Ball, P
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 : 21 - 27